Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Research progress in liver tissue engineering.

Lei Zhang1, Zheng Guan1, Jun-Song Ye1

  • 1BRC, First Hospital of Kun Ming (Affiliated Calmette Hospital of Kunming Medical University), Kunming, China.

Bio-Medical Materials and Engineering
|April 5, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of mesenchymal stem cell-derived extracellular vesicles therapy for Parkinson's disease: A systematic review of preclinical studies.

World journal of stem cells·2025
Same author

Mesenchymal stem cell therapy for liver fibrosis need "partner": Results based on a meta-analysis of preclinical studies.

World journal of gastroenterology·2024
Same author

miR-666-3p Mediates the Protective Effects of Mesenchymal Stem Cell-derived Exosomes Against Oxygen-glucose Deprivation and Reoxygenation- induced Cell Injury in Brain Microvascular Endothelial Cells via Mitogen-activated Protein Kinase Pathway.

Current neurovascular research·2021
Same author

The low-expression programming of 11β-HSD2 mediates osteoporosis susceptibility induced by prenatal caffeine exposure in male offspring rats.

British journal of pharmacology·2020
Same author

Mesenchymal Stem Cell-derived Exosomes Rescue Oxygen-Glucose Deprivation-induced Injury in Endothelial Cells.

Current neurovascular research·2020
Same author

Immunothérapie adoptive antivirale après allogreffe de cellules souches hématopoïétiques.

Virologie (Montrouge, France)·2020

Liver tissue engineering offers a solution to liver donor shortages by creating new livers in vitro. Key elements for success include cell sources, biocompatible scaffolds, and bioreactors to mimic in vivo conditions.

Area of Science:

  • Regenerative Medicine
  • Biomedical Engineering
  • Hepatology

Background:

  • Liver transplantation is the primary treatment for end-stage liver diseases (ESLD).
  • A significant shortage of liver donors limits transplantation accessibility.
  • Liver tissue engineering presents a promising alternative to address donor scarcity.

Purpose of the Study:

  • To review recent advancements in liver tissue engineering.
  • To highlight the critical components: cell sources, scaffolds, and bioreactors.
  • To identify the gap between research progress and clinical application.

Main Methods:

  • Review of current literature on cell sources for liver tissue engineering (hepatocytes, cell lines, stem cells).
  • Analysis of scaffold requirements (biocompatibility, microstructure, degradation) and types (decellularized livers, collagens, plastics).
Keywords:
Liver tissue engineeringbiomaterialbioreactorhepatocytemesenchymal stem cell

Related Experiment Videos

  • Examination of bioreactor roles in providing essential microenvironments (oxygen, nutrients, growth factors).

    • Main Results:

    • Various cell sources show potential for liver regeneration.
    • Scaffolds must possess specific characteristics for optimal cell function.
    • Bioreactors are crucial for mimicking in vivo conditions to support cell development.
    • Significant progress has been made in all three key areas of liver tissue engineering.

    Conclusions:

    • Liver tissue engineering requires careful consideration of cell sources, scaffolds, and bioreactors.
    • Despite advancements, a gap persists between research and practical application.
    • Further development is needed to translate tissue-engineered livers into clinical practice.